See more : América Móvil, S.A.B. de C.V. (AMXB.MX) Income Statement Analysis – Financial Results
Complete financial analysis of The Pennant Group, Inc. (PNTG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of The Pennant Group, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Al Rajhi REIT Fund (4340.SR) Income Statement Analysis – Financial Results
- Sassy Gold Corp. (SASY.CN) Income Statement Analysis – Financial Results
- Community Bank System, Inc. (CBU) Income Statement Analysis – Financial Results
- AFC Gamma, Inc. (AFCG) Income Statement Analysis – Financial Results
- Morepen Laboratories Limited (MOREPENLAB.BO) Income Statement Analysis – Financial Results
The Pennant Group, Inc. (PNTG)
About The Pennant Group, Inc.
The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors, who are independent or who require some support. As of December 31, 2021, the company operated 88 home health and hospice agencies, and 54 senior living communities with 4127 Senior Living units in Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
---|---|---|---|---|---|---|---|---|
Revenue | 544.89M | 473.24M | 439.69M | 390.95M | 338.53M | 286.06M | 250.99M | 217.23M |
Cost of Revenue | 477.86M | 414.66M | 393.96M | 336.07M | 293.92M | 243.62M | 218.58M | 188.94M |
Gross Profit | 67.04M | 58.59M | 45.74M | 54.89M | 44.62M | 42.44M | 32.41M | 28.29M |
Gross Profit Ratio | 12.30% | 12.38% | 10.40% | 14.04% | 13.18% | 14.84% | 12.91% | 13.02% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 36.67M | 33.98M | 36.26M | 31.30M | 35.14M | 18.84M | 14.46M | 12.45M |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 36.67M | 33.98M | 36.26M | 31.30M | 35.14M | 18.84M | 14.46M | 12.45M |
Other Expenses | 0.00 | 4.90M | 4.78M | 4.68M | 3.81M | 2.96M | 2.54M | 2.86M |
Operating Expenses | 41.87M | 38.88M | 41.04M | 35.97M | 38.95M | 21.81M | 17.01M | 15.30M |
Cost & Expenses | 519.72M | 453.54M | 435.00M | 372.04M | 332.86M | 265.43M | 235.59M | 204.24M |
Interest Income | 0.00 | 3.82M | 1.94M | 1.24M | 410.00K | 0.00 | 0.00 | 0.00 |
Interest Expense | 5.92M | 3.82M | 1.94M | 1.24M | 410.00K | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 5.13M | 4.90M | 4.78M | 4.68M | 4.03M | 2.96M | 2.54M | 2.86M |
EBITDA | 30.64M | 24.60M | 9.46M | 23.82M | 9.48M | 23.60M | 17.95M | 15.84M |
EBITDA Ratio | 5.62% | 5.19% | 2.15% | 6.09% | 2.80% | 8.25% | 7.15% | 7.29% |
Operating Income | 25.17M | 19.67M | 4.70M | 18.92M | 5.67M | 20.63M | 15.40M | 12.98M |
Operating Income Ratio | 4.62% | 4.16% | 1.07% | 4.84% | 1.67% | 7.21% | 6.14% | 5.98% |
Total Other Income/Expenses | -5.59M | -3.85M | -1.97M | -1.01M | -410.00K | 0.00 | 0.00 | 0.00 |
Income Before Tax | 19.58M | 8.89M | 2.73M | 17.90M | 5.26M | 20.63M | 15.40M | 12.98M |
Income Before Tax Ratio | 3.59% | 1.88% | 0.62% | 4.58% | 1.55% | 7.21% | 6.14% | 5.98% |
Income Tax Expense | 5.67M | 1.65M | 582.00K | 2.35M | 2.09M | 4.35M | 5.38M | 5.07M |
Net Income | 13.38M | 6.64M | 2.15M | 15.74M | 2.55M | 15.68M | 9.87M | 7.89M |
Net Income Ratio | 2.46% | 1.40% | 0.49% | 4.03% | 0.75% | 5.48% | 3.93% | 3.63% |
EPS | 0.45 | 0.23 | 0.08 | 0.56 | 0.09 | 0.56 | 0.35 | 0.28 |
EPS Diluted | 0.44 | 0.22 | 0.07 | 0.52 | 0.09 | 0.56 | 0.35 | 0.28 |
Weighted Avg Shares Out | 29.86M | 29.06M | 28.41M | 28.03M | 27.84M | 27.83M | 27.83M | 28.00M |
Weighted Avg Shares Out (Dil) | 30.19M | 30.16M | 30.64M | 30.23M | 29.59M | 28.00M | 28.00M | 28.00M |
Here's Why The Pennant Group, Inc. (PNTG) is a Great Momentum Stock to Buy
What Makes The Pennant Group, Inc. (PNTG) a New Buy Stock
Pennant Acquires Two Senior Living Communities in Utah
The Pennant Group, Inc. (PNTG) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Pennant Reports Fourth Quarter and Fiscal Year 2023 Results
Ahead of The Pennant Group, Inc. (PNTG) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Pennant Announces Fourth Quarter and Year-End 2023 Earnings Release and Call
The Pennant Group, Inc. (PNTG) Is Attractively Priced Despite Fast-paced Momentum
The Pennant Group, Inc. (PNTG) Surges 8.4%: Is This an Indication of Further Gains?
Pennant and John Muir Health Enter into a Home Health Joint Venture in the Bay Area, California
Source: https://incomestatements.info
Category: Stock Reports